Showing 1 - 9 results of 9 for search 'J Robert Lane', query time: 0.04s Refine Results
  1. 1
    GRKs as Key Modulators of Opioid Receptor Function

    GRKs as Key Modulators of Opioid Receptor Function by Laura Lemel, J Robert Lane, Meritxell Canals

    Published 2020-11-01
    Get full text
    Article
  2. 2
    Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10

    Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10 by Herman D. Lim, J. Robert Lane, Meritxell Canals, Martin J. Stone

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D<sub>1</sub> Receptor

    Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D<sub>1</sub> Receptor by Tim J. Fyfe, Peter J. Scammells, J. Robert Lane, Ben Capuano

    Published 2021-06-01
    Get full text
    Article
  4. 4
    Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’

    Reply to ‘Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal side-effects’ by David A. Sykes, J. Robert Lane, Monika Szabo, Ben Capuano, Jonathan A. Javitch, Steven J. Charlton

    Published 2018-09-01
    Get full text
    Article
  5. 5
    New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling

    New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D2 receptor regulation and signaling by Anika Mann, Alastair C. Keen, Hanka Mark, Pooja Dasgupta, Jonathan A. Javitch, Meritxell Canals, Stefan Schulz, J. Robert Lane

    Published 2021-04-01
    Get full text
    Article
  6. 6
    The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors.

    The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. by Ravi Kumar Verma, Ara M Abramyan, Mayako Michino, R Benjamin Free, David R Sibley, Jonathan A Javitch, J Robert Lane, Lei Shi

    Published 2018-01-01
    Get full text
    Article
  7. 7
    Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism

    Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism by J Robert Lane, Ara M Abramyan, Pramisha Adhikari, Alastair C Keen, Kuo-Hao Lee, Julie Sanchez, Ravi Kumar Verma, Herman D Lim, Hideaki Yano, Jonathan A Javitch, Lei Shi

    Published 2020-01-01
    Get full text
    Article
  8. 8
    OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz

    OZITX, a pertussis toxin-like protein for occluding inhibitory G protein signalling including Gαz by Alastair C. Keen, Maria Hauge Pedersen, Laura Lemel, Daniel J. Scott, Meritxell Canals, Dene R. Littler, Travis Beddoe, Yuki Ono, Lei Shi, Asuka Inoue, Jonathan A. Javitch, J. Robert Lane

    Published 2022-03-01
    Get full text
    Article
  9. 9
    Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine

    Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine by Despoina Aslanoglou, Suzanne Bertera, Laura Friggeri, Marta Sánchez-Soto, Jeongkyung Lee, Xiangning Xue, Ryan W. Logan, J. Robert Lane, Vijay K. Yechoor, Peter J. McCormick, Jens Meiler, R. Benjamin Free, David R. Sibley, Rita Bottino, Zachary Freyberg

    Published 2022-08-01
    Get full text
    Article

Search Tools: